We chose to investigate transforming growth factor β1 (TGFβ1), a pro-fibrotic cytokine that has been implicated in the pathogenesis of FSGS and is highly expressed in podocytes from patients with idiopathic FSGS [23,24]. This evidence concerns the gene TGFB1 and focal segmental glomerulosclerosis.